ARCHIVES

Assembly of Scientists, started as a result of conflict of interest controversy, plans Sept. 14 meeting.

This article is from The Cancer Letter archive.

Vol. 31 No. 32 | September 9, 2005

Download PDF Visit The Full Archive

Related Articles

Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”

September 9, 1994

FDA orders “limited distribution” for lung cancer drug Iressa.

June 24, 2005

IL13-PE38 Looks Promising In Early Tests Against Gioma

September 27, 2002

In Brief: Fischinger Hints of “New Player” At FCRF; Gigliotti Named Cancer Control Science Director

December 12, 1986

NCI Cooperative Group, Cancer Center Trials Listed

April 25, 2008

Skipper’s Impact: Drugs Curing 40,000 a Year

March 27, 1981